Two Gastroenteritis Outbreaks Caused by GII Noroviruses: Host Susceptibility and HBGA Phenotypes

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Jin, Miao ^a,b   He, Yaqing ^d   Li, Huiying ^a   Huang, Pengwei ^b   Zhong, Weiming ^b   Yang, Hong ^d   Zhang, Hailong ^d   Tan, Ming ^b,c   Duan, Zhao Jun ^a  

^a National Institute for Viral Disease Control and Prevention   (China)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d SHENZHEN CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIGEN; HISTO BLOOD GROUP ANTIGEN; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS RNA;

ARTICLE; CHINA; CONTROLLED STUDY; DNA SEQUENCE; EPIDEMIC; FECES ANALYSIS; HOST SUSCEPTIBILITY; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; NOROVIRUS; NUCLEOTIDE SEQUENCE; PHENOTYPE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVA ANALYSIS; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; VIRAL GASTROENTERITIS; VIRUS DETECTION; VIRUS RESISTANCE; VIRUS STRAIN; WATER SAMPLING; CALICIVIRIDAE INFECTIONS; DISEASE PREDISPOSITION; FECES; GASTROENTERITIS; GENETICS; METABOLISM; MICROBIOLOGY; PHYLOGENY; PROTEIN CONFORMATION; SALIVA; VIROLOGY;

BLOOD GROUP ANTIGENS; CALICIVIRIDAE INFECTIONS; CHINA; DISEASE OUTBREAKS; DISEASE SUSCEPTIBILITY; FECES; GASTROENTERITIS; HUMANS; NOROVIRUS; PHENOTYPE; PHYLOGENY; PROTEIN CONFORMATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SALIVA; WATER MICROBIOLOGY;

EID: 84874592531     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058605     Document Type: Article

References (55)

1. Green KY, Chanock RM, Kapiakan AZ (2001) Human caliciviruses. Fields virology 4th ed Philadelphia:Lippincoott Williams&Wilkins.: 841-874.
2. Hedlund KO, Rubilar-Abreu E, Svensson L, (2000) Epidemiology of calicivirus infections in Sweden,. 1994-1998. J Infect Dis181Suppl 2: S275-280.
3. Inouye S, Yamashita K, Yamadera S, Yoshikawa M, Kato N, et al. (2000) Surveillance of viral gastroenteritis in Japan: pediatric cases and outbreak incidents. J Infect Dis181Suppl 2: S270-274.
4. Lopman BA, Reacher MH, Van Duijnhoven Y, Hanon FX, Brown D, et al. (2003) Viral gastroenteritis outbreaks in europe,. 1995-2000. Emerg Infect Dis 9: 90-96.
5. Fankhauser RL, Monroe SS, Noel JS, Humphrey CD, Bresee JS, et al. (2002) Epidemiologic and molecular trends of "Norwalk-like viruses" associated with outbreaks of gastroenteritis in the United States. J Infect Dis186: 1-7.
6. Zheng DP, Ando T, Fankhauser RL, Beard RS, Glass RI, et al. (2006) Norovirus classification and proposed strain nomenclature. Virology 346: 312-323.
7. White PA, Hansman GS, Li A, Dable J, Isaacs M, et al. (2002) Norwalk-like virus 95/96-US strain is a major cause of gastroenteritis outbreaks in Australia. J Med Virol 68: 113-118.
8. Widdowson MA, Cramer EH, Hadley L, Bresee JS, Beard RS, et al. (2004) Outbreaks of acute gastroenteritis on cruise ships and on land: identification of a predominant circulating strain of norovirus--United States,. 2002. J Infect Dis190: 27-36.
9. Tan M, Jiang X, (2005) Norovirus and its histo-blood group antigen receptors: an answer to a historical puzzle. Trends Microbiol 13: 285-293.
10. Tan M, Jiang X, (2007) Norovirus-host interaction: implications for disease control and prevention. Expert Rev Mol Med 9: 1-22.
11. Tan M, Jiang X, (2010) Norovirus gastroenteritis, carbohydrate receptors, and animal models. PLoS pathogens 6: e1000983.
12. Tan M, Jiang X (2010) Virus-Host Interaction and Celluar Receptors of Caliciviruses. In: Hansman G, Jiang X, Green K, editors. Caliciruses. Norwich: Caister Academic Press. pp. 111-130.
13. Tan M, Jiang X, (2011) Norovirus-host interaction: Multi-selections by human histo-blood group antigens. Trends in microbiology 19: 382-388.
14. Hutson AM, Atmar RL, Estes MK, (2004) Norovirus disease: changing epidemiology and host susceptibility factors. Trends Microbiol 12: 279-287.
15. Huang P, Farkas T, Zhong W, Tan M, Thornton S, et al. (2005) Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J Virol 79: 6714-6722.
16. Huang P, Farkas T, Marionneau S, Zhong W, Ruvoen-Clouet N, et al. (2003) Noroviruses Bind to Human ABO, Lewis, and Secretor Histo-Blood Group Antigens: Identification of 4 Distinct Strain-Specific Patterns. J Infect Dis188: 19-31.
17. Tan M, Hegde RS, Jiang X, (2004) The P domain of norovirus capsid protein forms dimer and binds to histo-blood group antigen receptors. J Virol 78: 6233-6242.
18. Tan M, Zhong W, Song D, Thornton S, Jiang X, (2004) E. coli-expressed recombinant norovirus capsid proteins maintain authentic antigenicity and receptor binding capability. J Med Virol 74: 641-649.
19. Hutson AM, Atmar RL, Marcus DM, Estes MK, (2003) Norwalk virus-like particle hemagglutination by binding to h histo-blood group antigens. J Virol 77: 405-415.
20. Tan M, Jiang X, (2005) The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors. Journal of Virology 79: 14017-14030.
21. Harrington PR, Lindesmith L, Yount B, Moe CL, Baric RS, (2002) Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice. J Virol 76: 12335-12343.
22. Bu W, Mamedova A, Tan M, Xia M, Jiang X, et al. (2008) Structural basis for the receptor binding specificity of Norwalk virus. J Virol 82: 5340-5347.
23. Cao S, Lou Z, Tan M, Chen Y, Liu Y, et al. (2007) Structural basis for the recognition of blood group trisaccharides by norovirus. J Virol 81: 5949-5957.
24. Chen Y, Tan M, Xia M, Hao N, Zhang XC, et al. (2011) Crystallography of a lewis-binding norovirus, elucidation of strain-specificity to the polymorphic human histo-blood group antigens. PLoS pathogens 7: e1002152.
25. Choi JM, Hutson AM, Estes MK, Prasad BV, (2008) Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus. Proc Natl Acad Sci U S A 105: 9175-9180.
26. Hansman GS, Biertumpfel C, Georgiev I, McLellan JS, Chen L, et al. (2011) Crystal Structures of GII.10 and GII.12 Norovirus Protruding Domains in Complex with Histo-Blood Group Antigens Reveal Details for a Potential Site of Vulnerability. J Virol 85: 6687-6701.
27. Shanker S, Choi JM, Sankaran B, Atmar RL, Estes MK, et al. (2011) Structural analysis of histo-blood group antigen binding specificity in a norovirus GII.4 epidemic variant: implications for epochal evolution. J Virol 85: 8635-8645.
28. Tan M, Xia M, Cao S, Huang P, Farkas T, et al. (2008) Elucidation of strain-specific interaction of a GII-4 norovirus with HBGA receptors by site-directed mutagenesis study. Virology 379: 324-334.
29. Tan M, Xia M, Chen Y, Bu W, Hegde RS, et al. (2009) Conservation of carbohydrate binding interfaces: evidence of human HBGA selection in norovirus evolution. PLoS One 4: e5058.
30. de Rougemont A, Ruvoen-Clouet N, Simon B, Estienney M, Elie-Caille C, et al. (2011) Qualitative and quantitative analysis of the binding of GII.4 norovirus variants onto human blood group antigens. J Virol 85: 4057-4070.
31. Hutson AM, Atmar RL, Graham DY, Estes MK, (2002) Norwalk virus infection and disease is associated with ABO histo-blood group type. J Infect Dis185: 1335-1337.
32. Lindesmith L, Moe C, Marionneau S, Ruvoen N, Jiang X, et al. (2003) Human susceptibility and resistance to Norwalk virus infection. Nat Med 9: 548-553.
33. Hutson AM, Airaud F, LePendu J, Estes MK, Atmar RL, (2005) Norwalk virus infection associates with secretor status genotyped from sera. J Med Virol 77: 116-120.
34. Frenck R, Bernstein DI, Xia M, Huang P, Zhong W, et al. (2012) Predicting Susceptibility to Norovirus GII.4 by Use of a Challenge Model Involving Humans. J Infect Dis206: 1386-1393.
35. Carlsson B, Kindberg E, Buesa J, Rydell GE, Lidon MF, et al. (2009) The G428A nonsense mutation in FUT2 provides strong but not absolute protection against symptomatic GII.4 Norovirus infection. PLoS One 4: e5593.
36. Kindberg E, Akerlind B, Johnsen C, Knudsen JD, Heltberg O, et al. (2007) Host genetic resistance to symptomatic norovirus (GGII.4) infections in Denmark. J Clin Microbiol 45: 2720-2722.
37. Tan M, Jin M, Xie H, Duan Z, Jiang X, et al. (2008) Outbreak studies of a GII-3 and a GII-4 norovirus revealed an association between HBGA phenotypes and viral infection. J Med Virol 80: 1296-1301.
38. Bucardo F, Kindberg E, Paniagua M, Grahn A, Larson G, et al. (2009) Genetic susceptibility to symptomatic norovirus infection in Nicaragua. J Med Virol 81: 728-735.
39. Le Guyader FS, Krol J, Ambert-Balay K, Ruvoen-Clouet N, Desaubliaux B, et al. (2010) Comprehensive analysis of a norovirus-associated gastroenteritis outbreak, from the environment to the consumer. J Clin Microbiol 48: 915-920.
40. Nordgren J, Kindberg E, Lindgren PE, Matussek A, Svensson L, (2010) Norovirus gastroenteritis outbreak with a secretor-independent susceptibility pattern, Sweden. Emerg Infect Dis 16: 81-87.
41. Thorven M, Grahn A, Hedlund KO, Johansson H, Wahlfrid C, et al. (2005) A homozygous nonsense mutation (428G-->A) in the human secretor (FUT2) gene provides resistance to symptomatic norovirus (GGII) infections. J Virol 79: 15351-15355.
42. Lindesmith L, Moe C, Lependu J, Frelinger JA, Treanor J, et al. (2005) Cellular and humoral immunity following Snow Mountain virus challenge. J Virol 79: 2900-2909.
43. Halperin T, Vennema H, Koopmans M, Kahila Bar-Gal G, Kayouf R, et al. (2008) No association between histo-blood group antigens and susceptibility to clinical infections with genogroup II norovirus. J Infect Dis197: 63-65.
44. Rockx BH, Vennema H, Hoebe CJ, Duizer E, Koopmans MP, (2005) Association of histo-blood group antigens and susceptibility to norovirus infections. J Infect Dis191: 749-754.
45. Tan M, Jiang X, (2008) Association of histo-blood group antigens with susceptibility to norovirus infection may be strain-specific rather than genogroup dependent. J Infect Dis198: 940-941 author reply 942-943.
46. Chan MC, Wong YP, Sung JJ, Leung WK (2008) Histo-blood group antigens and susceptibility to infection with norovirus genogroup II genotype 4. J Infect Dis198: 940; author reply 942-943.
47. Jin M, Xie HP, Duan ZJ, Liu N, Zhang Q, et al. (2008) Emergence of the GII4/2006b variant and recombinant noroviruses in China. J Med Virol 80: 1997-2004.
48. Katayama H, Shimasaki A, Ohgaki S, (2002) Development of a virus concentration method and its application to detection of enterovirus and norwalk virus from coastal seawater. Appl Environ Microbiol 68: 1033-1039.
49. Kageyama T, Kojima S, Shinohara M, Uchida K, Fukushi S, et al. (2003) Broadly Reactive and Highly Sensitive Assay for Norwalk-Like Viruses Based on Real-Time Quantitative Reverse Transcription-PCR. J Clin Microbiol 41: 1548-1557.
50. Yan H, Yagyu F, Okitsu S, Nishio O, Ushijima H, (2003) Detection of norovirus (GI, GII), Sapovirus and astrovirus in fecal samples using reverse transcription single-round multiplex PCR. J Virol Methods 114: 37-44.
51. Tan M, Fang P, Chachiyo T, Xia M, Huang P, et al. (2008) Noroviral P particle: Structure, function and applications in virus-host interaction. Virology 382: 115-123.
52. Tan M, Huang P, Meller J, Zhong W, Farkas T, et al. (2003) Mutations within the P2 Domain of Norovirus Capsid Affect Binding to Human Histo-Blood Group Antigens: Evidence for a Binding Pocket. J Virol 77: 12562-12571.
53. Lindesmith LC, Donaldson EF, Lobue AD, Cannon JL, Zheng DP, et al. (2008) Mechanisms of GII.4 norovirus persistence in human populations. PLoS Med 5: e31.
54. Rydell GE, Nilsson J, Rodriguez-Diaz J, Ruvoen-Clouet N, Svensson L, et al. (2009) Human noroviruses recognize sialyl Lewis x neoglycoprotein. Glycobiology 19: 309-320.
55. Boon D, Mahar JE, Abente EJ, Kirkwood CD, Purcell RH, et al. (2011) Comparative evolution of GII.3 and GII.4 norovirus over a 31-year period. J Virol 85: 8656-8666.